Şirket borçlanma araçları
Aşağıda, vadeye kalan getiriye göre sıralanmış Eli Lilly and Company tahvillerinin listesi bulunmaktadır. Yatırımcılar, piyasa oynaklığı zamanlarında artan istikrarları nedeniyle genellikle bir şirketin tahvillerini tercih ederler. Fiyatları, getirileri ve diğer istatistikleri inceleyin ve güvenilir bir yatırım bulun.
Sembol | YTM % | Hacim | Fiyat % | Kupon % | Vade Tarihi | Ödenmemiş tutar | Nominal değer | Asgari brm tutarı | İhraççı |
|---|---|---|---|---|---|---|---|---|---|
| 5,58% | 0 | 56,39% | 1,625% | 2043-09-14 | 250 M GBP | 1.000,00 GBP | 100.000,00 GBP | Eli Lilly & Co. | |
| 5,54% | 881 K | 100,83% | 5,600% | 2065-02-12 | 750 M USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 5,54% | 749 K | 93,28% | 5,100% | 2064-02-09 | 1,5 B USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 5,52% | 660 K | 101,92% | 5,650% | 2065-10-15 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 5,52% | 650 K | 95,10% | 5,200% | 2064-08-14 | 750 M USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 5,52% | 30 K | 89,99% | 4,650% | 2044-06-15 | 38,34 M USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 5,50% | 74 K | 91,30% | 4,950% | 2063-02-27 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 5,45% | 0 | 80,09% | 4,150% | 2059-03-15 | 591,29 M USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 5,42% | 1,83 M | 94,58% | 5,050% | 2054-08-14 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 5,42% | 6,46 M | 101,81% | 5,550% | 2055-10-15 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 5,41% | 2,79 M | 94,04% | 5,000% | 2054-02-09 | 1,5 B USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 5,41% | 1,52 M | 101,23% | 5,500% | 2055-02-12 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 5,41% | 588 K | 92,37% | 4,875% | 2053-02-27 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 5,35% | 6 K | 55,22% | 2,500% | 2060-09-15 | 850 M USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 5,34% | 0 | 81,59% | 3,950% | 2049-03-15 | 958,15 M USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 5,33% | 0 | 82,50% | 3,950% | 2047-05-15 | 346,95 M USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 5,33% | 1,57 M | 58,33% | 2,250% | 2050-05-15 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 5,29% | 100 K | 81,27% | 3,700% | 2045-03-01 | 386,8 M USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 5,19% | 0 | 87,58% | 3,875% | 2039-03-15 | 240,25 M USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 4,77% | 20 K | 110,47% | 5,950% | 2037-11-15 | 266,83 M USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 4,68% | 18 K | 116,38% | 6,770% | 2036-01-01 | 158,56 M USD | 1.000,00 USD | 1.000,00 USD | Eli Lilly & Co. | |
| 4,60% | 14 M | 102,25% | 4,900% | 2035-10-15 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 4,60% | 62 K | 108,17% | 5,550% | 2037-03-15 | 444,73 M USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 4,52% | 6,42 M | 104,22% | 5,100% | 2035-02-12 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 4,44% | 1,37 M | 101,17% | 4,600% | 2034-08-14 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 4,41% | 45 K | 100,02% | 5,000% | 2026-02-27 | 750 M USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 4,39% | 559 K | 102,14% | 4,700% | 2034-02-09 | 1,5 B USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 4,22% | 0 | 48,01% | 1,375% | 2061-09-14 | 700 M EUR | 1.000,00 EUR | 100.000,00 EUR | Eli Lilly & Co. | |
| 4,22% | 340 K | 102,90% | 4,700% | 2033-02-27 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 4,21% | 6,65 M | 101,91% | 4,550% | 2032-10-15 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 4,16% | 1,26 M | 103,91% | 4,900% | 2032-02-12 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 4,11% | 0 | 53,28% | 1,125% | 2051-09-14 | 500 M EUR | 1.000,00 EUR | 100.000,00 EUR | Eli Lilly & Co. | |
| 4,04% | 0 | 64,75% | 1,700% | 2049-11-01 | 1 B EUR | 1.000,00 EUR | 100.000,00 EUR | Eli Lilly & Co. | |
| 3,97% | 7,3 M | 101,28% | 4,250% | 2031-03-15 | 750 M USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 3,91% | 8,11 M | 103,07% | 4,750% | 2030-02-12 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 3,81% | 2,19 M | 101,30% | 4,200% | 2029-08-14 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 3,81% | 0 | 98,75% | 3,375% | 2029-03-15 | 930,56 M USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 3,73% | 2,41 M | 102,14% | 4,500% | 2029-02-09 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 3,65% | 0 | 99,35% | 3,100% | 2027-05-15 | 401,45 M USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 3,63% | 26,56 M | 100,89% | 4,000% | 2028-10-15 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 3,63% | 231 K | 101,75% | 4,550% | 2028-02-12 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 3,63% | 4,26 M | 100,84% | 4,500% | 2027-02-09 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 3,62% | 736 K | 100,80% | 4,150% | 2027-08-14 | 750 M USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 3,61% | 1,08 M | 102,00% | 5,500% | 2027-03-15 | 364,32 M USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 2,97% | 0 | 83,42% | 0,500% | 2033-09-14 | 600 M EUR | 1.000,00 EUR | 100.000,00 EUR | Eli Lilly & Co. | |
| 2,81% | 0 | 88,59% | 0,625% | 2031-11-01 | 600 M EUR | 1.000,00 EUR | 100.000,00 EUR | Eli Lilly & Co. | |
| 2,57% | 0 | 98,18% | 2,125% | 2030-06-03 | 750 M EUR | 1.000,00 EUR | 100.000,00 EUR | Eli Lilly & Co. | |
| 2,26% | 0 | 99,81% | 1,625% | 2026-06-02 | 750 M EUR | 1.000,00 EUR | 100.000,00 EUR | Eli Lilly & Co. | |
| 0,30% | 20 K | 100,35% | 0,450% | 2028-05-24 | 400 M CHF | 5.000,00 CHF | 5.000,00 CHF | Eli Lilly & Co. | |
| — | 5 M | 100,72% | 4,188% | 2028-10-15 | 750 M USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. |